Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11366087 | 0.98 | MAPT (0.53) | MAPTTDP1OPRM1OPRL1ESR1 | |
| Hydrochloric Acid SCHEMBL8801549 | 0.98 | MAPT (0.53) | MAPTTDP1OPRM1OPRL1ESR1 | |
| SCHEMBL94623 | 0.93 | NPC1 (0.49) | MAPTCA12CA2CA9NPC1 | |
| SCHEMBL8980646 | 0.91 | NPC1 (0.51) | MAPTNPC1JAK2RAB9APAX8 | |
| SCHEMBL21337225 | 0.91 | NPC1 (0.51) | MAPTNPC1JAK2RAB9APAX8 | |
| SCHEMBL8980574 | 0.91 | NPC1 (0.51) | MAPTNPC1JAK2RAB9APAX8 | |
| SCHEMBL94910 | 0.91 | NPC1 (0.51) | MAPTNPC1JAK2RAB9APAX8 | |
| SCHEMBL21916561 | 0.91 | NPC1 (0.51) | MAPTNPC1JAK2RAB9APAX8 | |
| SCHEMBL6501802 | 0.91 | NPC1 (0.51) | MAPTNPC1JAK2RAB9APAX8 | |
| SCHEMBL10490549 | 0.91 | NPC1 (0.51) | MAPTNPC1JAK2RAB9APAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| EP-3842406-B1 | PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND | SHINETSU CHEMICAL CO (JP) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023142167-A1 | CATIONIC LIPID ANALOG, AND COMPOSITION AND USE THEREOF | 广州立得生物医药科技有限公司 | 2023-08-03 | — | — | WO | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-11654143-B2 | Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor | ACERTA PHARMA B.V. (NL) | 2023-05-23 | — | — | US | disclosed |
| US-11384041-B2 | Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-07-12 | — | — | US | disclosed |
| CN-109021605-B | Dye compound, composition comprising the same, and display device using the same | 三星显示有限公司 | 2022-04-01 | — | — | CN | disclosed |
| US-11247904-B2 | Scroll composite having amphiphilic substance inside and method for preparation of the same | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) | 2022-02-15 | — | — | US | disclosed |
| US-20210403638-A1 | BLOCK COPOLYMER INTRINSIC STRETCHABLE ELECTROLUMINESCENT ELASTOMER AND PREPARATION METHOD AND APPLICATION THEREOF | NANJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS (CN) | 2021-12-30 | — | — | US | disclosed |
| EP-0175271-A2 | Disazo dyes and their use in liquid crystal materials or in dyeing synthetic polymers or fibres | BASF Aktiengesellschaft (DE) | 1986-03-26 | — | — | EP | disclosed |
| EP-0155507-A2 | Azo dyes and liquid crystalline materials containing these dyes | BASF Aktiengesellschaft (DE) | 1985-09-25 | — | — | EP | disclosed |
| US-4500715-A | CHEMICAL INTERMEDIATES FOR PLANT SAFENING AGENTS AND DYES | BAYER AKTIENGESELLSCHAFT (DE) | 1985-02-19 | — | — | US | disclosed |
| US-4268438-A | Cationic 1,3,4-thiadiazole dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1981-05-19 | — | — | US | disclosed |
| US-4243584-A | Monoazo dyestuffs containing diazo component substituted by disulfimide and trifluoromethyl groups | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-06 | — | — | US | disclosed |
| US-4159265-A | Phenylazopyrazolo dyestuffs including disulfimide substituent | BAYER AKTIENGESELLSCHAFT (DE) | 1979-06-26 | — | — | US | disclosed |
| US-4036824-A | Disazo dyestuffs containing A-O-alkylene-O-SO3 H group | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | disclosed |
| US-4022763-A | Sulfaphenyl-azo-phenyl-azo-aminophenyl dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-10 | — | — | US | disclosed |
| US-3992395-A | Process for the preparation of chlorinated phenylhydroxylamines | RHONE-POULENC S.A. (FR) | 1976-11-16 | — | — | US | disclosed |
| US-3978039-A | POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384041-B2 | Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond | CBR3, CBR1, AOC2 | MAPT 4691/4885TDP1 3814/4885OPRM1 200/4885 |
| US-11247904-B2 | Scroll composite having amphiphilic substance inside and method for preparation of the same | PSAP, SGMS2, SDCBP | MAPT 3949/4885TDP1 4461/4885OPRM1 3983/4885 |
| US-11654143-B2 | Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor | BTK, JAK2, BCL9 | MAPT 4245/4885TDP1 1712/4885OPRM1 4436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.